Yongsheng Yu

929 total citations
21 papers, 743 citations indexed

About

Yongsheng Yu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Yongsheng Yu has authored 21 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Immunology. Recurrent topics in Yongsheng Yu's work include interferon and immune responses (4 papers), Biochemical effects in animals (4 papers) and Inflammasome and immune disorders (3 papers). Yongsheng Yu is often cited by papers focused on interferon and immune responses (4 papers), Biochemical effects in animals (4 papers) and Inflammasome and immune disorders (3 papers). Yongsheng Yu collaborates with scholars based in China, Egypt and Japan. Yongsheng Yu's co-authors include Yuefan Zhang, Xianxian Zhao, Yü Liu, Jingwen Song, Hao Zheng, Zhigang Zhang, Li Su, Minghua Zhang, Jinhua Cai and Wenwen Cai and has published in prestigious journals such as Journal of Clinical Investigation, British Journal of Pharmacology and Journal of Investigative Dermatology.

In The Last Decade

Yongsheng Yu

21 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongsheng Yu China 12 313 273 153 152 136 21 743
Zhen Sun China 17 319 1.0× 184 0.7× 170 1.1× 119 0.8× 101 0.7× 41 812
Giovanna Piraino United States 18 357 1.1× 214 0.8× 208 1.4× 92 0.6× 122 0.9× 37 827
Chun‐Tao Lei China 16 353 1.1× 145 0.5× 110 0.7× 75 0.5× 86 0.6× 26 908
Li Shen China 16 165 0.5× 119 0.4× 99 0.6× 80 0.5× 103 0.8× 38 574
U. Ungethüm Switzerland 13 263 0.8× 352 1.3× 270 1.8× 78 0.5× 181 1.3× 20 917
Xi Jiang China 14 366 1.2× 173 0.6× 200 1.3× 39 0.3× 48 0.4× 27 740
Elsa Maymó‐Masip Spain 17 387 1.2× 259 0.9× 254 1.7× 242 1.6× 106 0.8× 39 983
Mingwei Sheng China 15 308 1.0× 125 0.5× 187 1.2× 61 0.4× 148 1.1× 45 768
Zhuqing Rao China 13 307 1.0× 293 1.1× 171 1.1× 32 0.2× 149 1.1× 25 692
Kathryn M. Spitler United States 15 285 0.9× 152 0.6× 125 0.8× 126 0.8× 69 0.5× 18 749

Countries citing papers authored by Yongsheng Yu

Since Specialization
Citations

This map shows the geographic impact of Yongsheng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongsheng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongsheng Yu more than expected).

Fields of papers citing papers by Yongsheng Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongsheng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongsheng Yu. The network helps show where Yongsheng Yu may publish in the future.

Co-authorship network of co-authors of Yongsheng Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongsheng Yu. A scholar is included among the top collaborators of Yongsheng Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongsheng Yu. Yongsheng Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Guang, Yuan Gao, Yulin Ma, et al.. (2025). Oligo-peptide I-C-F-6 mitigates polymicrobial sepsis-induced cardiac dysfunction in mice. European Journal of Pharmacology. 996. 177545–177545. 1 indexed citations
2.
Liu, Yu, et al.. (2022). XMU-MP-1 protects heart from ischemia/reperfusion injury in mice through modulating Mst1/AMPK pathway. European Journal of Pharmacology. 919. 174801–174801. 20 indexed citations
3.
Kong, De-Pei, Juan Lv, Nanning Lv, et al.. (2022). Gelsevirine improves age-related and surgically induced osteoarthritis in mice by reducing STING availability and local inflammation. Biochemical Pharmacology. 198. 114975–114975. 27 indexed citations
4.
Yu, Yongsheng, Wen‐Li Jiang, Chenxi Zhang, et al.. (2021). Cyclic GMP-AMP promotes the acute phase response and protects against Escherichia coli infection in mice. Biochemical Pharmacology. 188. 114541–114541. 5 indexed citations
5.
Zhang, Zhigang, et al.. (2021). Treatment with XMU-MP-1 erases hyperglycaemic memory in hearts of diabetic mice. Biochemical Pharmacology. 188. 114574–114574. 10 indexed citations
6.
Yu, Yongsheng, et al.. (2021). Cytosolic DNA‒Mediated STING-Dependent Inflammation Contributes to the Progression of Psoriasis. Journal of Investigative Dermatology. 142(3). 898–906.e4. 30 indexed citations
7.
Zhang, Qian, et al.. (2021). Anti-Inflammatory Dipeptide, a Metabolite from Ambioba Secretion, Protects Cerebral Ischemia Injury by Blocking Apoptosis Via p-JNK/Bax Pathway. Frontiers in Pharmacology. 12. 689007–689007. 3 indexed citations
8.
Liu, Yulan, Qian Zhang, Yuchen Guo, et al.. (2021). MLIF Modulates Microglia Polarization in Ischemic Stroke by Targeting eEF1A1. Frontiers in Pharmacology. 12. 32 indexed citations
9.
Zhang, Zhigang, et al.. (2020). Exercise training suppresses Mst1 activation and attenuates myocardial dysfunction in mice with type 1 diabetes. Canadian Journal of Physiology and Pharmacology. 98(11). 777–784. 7 indexed citations
10.
Yu, Yongsheng, et al.. (2018). Exogenous IL‐19 attenuates acute ischaemic injury and improves survival in male mice with myocardial infarction. British Journal of Pharmacology. 176(5). 699–710. 22 indexed citations
11.
Yu, Yongsheng, et al.. (2018). STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis. Journal of Clinical Investigation. 129(2). 546–555. 306 indexed citations
12.
Yu, Yongsheng, et al.. (2018). Treatment with D-β-hydroxybutyrate protects heart from ischemia/reperfusion injury in mice. European Journal of Pharmacology. 829. 121–128. 60 indexed citations
13.
Zhang, Yi, Yongsheng Yu, Zhenghao Tang, Xiaohua Chen, & Guoqing Zang. (2014). Round pneumonia in an adult.. PubMed. 45(1). 207–13. 4 indexed citations
14.
Cai, Wenwen, Minghua Zhang, Yongsheng Yu, & Jinhua Cai. (2012). Treatment with hydrogen molecule alleviates TNFα-induced cell injury in osteoblast. Molecular and Cellular Biochemistry. 373(1-2). 1–9. 33 indexed citations
15.
Zheng, Hao & Yongsheng Yu. (2012). Chronic hydrogen-rich saline treatment attenuates vascular dysfunction in spontaneous hypertensive rats. Biochemical Pharmacology. 83(9). 1269–1277. 34 indexed citations
16.
Zhang, Lichao, Zhenzhen Li, Yongsheng Yu, et al.. (2011). Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Are Involved in Sinoaortic Denervation-Induced Cardiovascular Hypertrophy in Rats. Biological and Pharmaceutical Bulletin. 34(9). 1398–1403. 8 indexed citations
17.
18.
Yu, Yongsheng, He‐Hui Xie, Ling Li, et al.. (2010). Effects of low-dose ketanserin on atherosclerosis in rats and rabbits. Canadian Journal of Physiology and Pharmacology. 88(11). 1054–1060. 10 indexed citations
19.
Li, Ling, Lei Zhao, Yongsheng Yu, et al.. (2009). Sirt1 hyperexpression in SHR heart related to left ventricular hypertrophy. Canadian Journal of Physiology and Pharmacology. 87(1). 56–62. 34 indexed citations
20.
Fang, Jianqiao, et al.. (1998). Influence of moxibustion on collagen-induced arthritis in mice.. PubMed. 12(4). 421–6. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026